Interventional left atrial appendage closure vs. novel anticoagulation agents in atrial fibrillation patients indicated for long term anti-coagulation (PRAGUE-17 study)

Conclusion The PRAGUE-17 trial will determine if LAA occlusion is non-inferior to treatment with NOAC in moderate to high-risk AF patients.

Source: American Heart Journal - October 11, 2016 Category: Cardiology Source Type: research